... families. Factor V mutation was present in the 51 propositi and in 84 out of 125 family members (81 heterozygous, 3 homozygous). Venous thrombosis was observed in all the propositi, in 17 of the 84 family members with the mutation and in 6 of the 41 with a normal APC resistance test and no mutation...

... of a strategy to investigate thrombomodulin gene mutation in arterial and venous thrombosis. 28 4 2009 © 1996 S. Karger AG, Basel 1996 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized...

...P. Bianchini; G.L. Bergonzini; B. Parma; B. Osima The relationship between the inhibition of venous thrombosis and antifactor Xa (AXa) plasma levels, measured as ex vivo AXa activity at the moment of experimental thrombosis induction, was evaluated in rats treated by different administration routes...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Activated protein C Venous thrombosis Anticoagulant cofactor function factor V Factor V APC resistance Mutation in FV gene Gene mutation H aem ostasis 1994;24:139...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Low-molecular-weight heparin Heparin Prevention Venous thrombosis...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Therapeutic trial Medicine Prophylaxis Venous thrombosis ll;rm osf:i*is Haemostasis...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Venous thrombosis Epidemiology Thrombosis prophylaxis Medical patients Low...

... molecular weight heparin Thrombin generation Venous thrombosis Haemostasis 1993;23(suppl 1):99 102 Elaine Gray Ana Padilla Trevor W. Barrowcliffe National Institute for Biological Standards and Control, Potters Bar, Herts, UK Antithrombotic Activity and Its Relationship to in vitro Anticoagulant...

...Björn Dahlbäck; Bengt Zöller; Andreas Hillarp Inherited resistance to activated protein C (APC) was recently discovered as a cause of familial throm-bophilia and is now known to be the most common genetic risk factor for venous thrombosis. In a majority of cases, APC resistance is associated...

... as LMWH is in the prophylaxis of venous thrombosis. Prophylaxis Venous thrombosis Experimental Heparin Hirudin Low-molecular-weight heparin 7 12 1992 10 05 1993 28 4 2009 © 1993 S. Karger AG, Basel 1993 Copyright / Drug Dosage / Disclaimer Copyright: All rights...

... anticoagulant Venous thrombosis Original Paper Haemostasis 1993;23:275-283 V Toschia A. Mottaa C. Castellia S. Gibellia C. Cimminiellob G.L. Molaro* A. Gibellia Prevalence and Clinical Significance of Antiphospholipid Antibodies to Noncardiolipin Antigens in Systemic Lupus erythematosus Departments...

.... Davis Medical Center. Department of Internal Medicine, and Kaiser Hospital, Sacramento, Calif., and Ferris State School of Pharmacy, Lansing, Mich.. USA Key Words Heparin Thrombophlebitis Anticoagulalion Venous thrombosis Treatment of Proximal Deep-Vein Thrombosis Using Subcutaneously Administered...

...A. Bernat; M. Sainte-Marie; C. Roque; V. Ingelaere; J.P. Maffrand; J.M. Herbert Procoagulant activity of the endothelium and of monocytes was induced by an intravenous administration of a low dose of endotoxin in the rabbit. Venous thrombosis induced by a 45-min stasis of the jugular vein...

... Monreal Ana María Angles Luís Monreal Javier Roncales Jasoné Monasterio Unit on Experimental Thrombosis, Universität Autónoma de Barcelona, Spain Effects of Recombinant Hirudin on D Dimer Levels before and after Experimental Venous Thrombosis Key Words Hirudin Heparin, low-molecular-weight Venous...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Heparin Therapy Bleeding Venous thrombosis Platelet count llæm o...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Recombinant hirudin Animal models Arteriolar thrombosis Venous thrombosis Bleeding time Haemostasis 1991 ;21(suppl 1...

... of these drugs should be compared to heparin, the reference substance, in an experimental venous thrombosis model. In this model, the effect of these r-hirudins on thrombus weight reduction were not identical. They varied depending on the original product ( E. coli or yeast). The growth-inhibiting activity of r...

...W. Raake; R.J. Klauser; H. Elling; P. Zeiller The dose- and time-dependent antithrombotic activity of recombinant hirudin (r-hirudin) was examined in a new animal model of venous thrombosis. For the evaluation of the antithrombotic activity of r-hirudin, an occluding thrombus was produced...

.... These effects of heparin were evident both shortly after (maximal anticoagulant effect) and long after (no anticoagulant effect) pretreatment. We think that, under the experimental conditions we used, heparin prevented venous thrombosis at least partially by protection of the endothelial cells, through unknown...

.... Thromboprophylaxis Heparin derivatives Venous thrombosis Thrombosis model Haemostasis 18: suppl. 3. pp. 69-72 (1988) © 1988 S. Karger AG, Basel 0301 - 0 147/88/0189-0069S2.75/0 Experimental Investigations on the Thrombosis-Preventing Effect of Low-Molecular-Weight Heparins G. Harbauer, A. Allendorf Department...